跳至主要内容
临床试验/EUCTR2011-001919-31-DK
EUCTR2011-001919-31-DK进行中(未招募)1 期

DALIAHA Danish Study of Low-dose Interferon Alpha Versus Hydroxyurea in the Treatment of Ph-negative Chronic Myeloid Neoplasias - A National Randomized Prospective Study With Focus on Efficacy, Toxicity and Quality of Life - DALIAH

Roskilde sygehus0 个研究点目标入组 200 人开始时间: 2011年8月24日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Male or female > 18 years of age
  • 2.Newly diagnosed or previously untreated patients with ET, PV or PMF including prefibrotic
  • myelofibrosis according to the WHO classification
  • 3.Active disease defined by one of the following criteria:
  • - need for phlebotomy
  • - leukocytosis > 10 mia/l
  • - thrombocytosis > 400 mia/l
  • - constitutional symptoms (fatigue, weight loss, night sweats or
  • fewer > 38 degrees celsius)
  • - Pruritus
  • - splenomegali causing symptoms
  • - previous thrombosis
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 100

排除标准

  • -Fertile women without a negative pregnancy test
  • -Other malignant disease within last 5 yaers
  • -ECOG performance score >/= 3
  • -Creatinine > 2x ULN
  • -Bilirubin > 1.5x ULN
  • -ALAT > 3x ULN
  • -Previous psyciatric disorder (depression)
  • -active autoimmune disease
  • -Uncontrolled thyroid disease

研究者

相似试验